Estimated Global Healthcare Expenditure To Treat Diabetes In 2017 And 2045 (in Billion U.s. Dollars)
727727776776 About this statistic Show source Statistics on "Diabetes" Related Studies: Available to Download in PDF or PPTX Format Everything On "Diabetes" in One Document: Edited and Divided into Handy Chapters. Including Detailed References. Continue reading >>
Diabetes 2030: Insights From Yesterday, Today, And Future Trends
Diabetes and its complications, deaths, and societal costs have a huge and rapidly growing impact on the United States. Between 1990 and 2010 the number of people living with diabetes tripled and the number of new cases annually (incidence) doubled.1 Adults with diabetes have a 50% higher risk of death from any cause than adults without diabetes, in addition to risk for myriad complications.2 Reducing this burden will require efforts on many fronts—from appropriate medical care to significant public health efforts and individual behavior change across the nation, through state- and community-specific efforts. Public awareness is a key first step. For this purpose, the Centers for Disease Control and Prevention (CDC) releases national diabetes statistics every 2 years, providing a point-in-time picture of diabetes for the country as a whole. However, state and metropolitan diabetes forecasts with projections several years into the future also are useful as health professionals and decision makers contemplate actions to address the diabetes epidemic. Therefore, the Institute for Alternative Futures (IAF) has prepared 2015, 2020, 2025, and 2030 diabetes forecasts for the entire United States, every state, and several metropolitan statistical areas, all of which are easily accessible on the Internet.3 This study shows how past trends, current data, and future projections provide valuable insights about the possible course of diabetes. Continue reading >>
The 5 Cost Drivers Of Diabetes Care
We know that the share of spending payers are dedicating to people with diabetes is on the rise. We also know why: the population of diabetics is increasing and the costs associated with treating them are becoming more expensive on a per capita basis.1, 2 However, to get a more complete picture of this cost equation, we need to first examine the cost drivers behind these two factors. 1. A demographic deluge Currently, diabetes affects more than 29 million people in the U.S., or 1 in 11 Americans.1 Another way to understand the scale of diabetes problem is to consider that 3700 people are now diagnosed with diabetes in the U.S. every day.3 These numbers are considerable in their own right, but what is most noteworthy is that the percentage of Americans being diagnosed is increasing. Between 1994 and 2014, the number of men diagnosed with a type of diabetes grew 113% and the percentage of women jumped 95%.4 Extrapolate this trend and things look even worse. Between 2015 and 2030, the number of people with diabetes is expected to increase by 54% to 55 million Americans.5 Additionally, the costs related to treating diabetes are expected to only increase as the disease becomes more commonplace. The corresponding annual medical and societal costs related to diabetes are expected to increase 53% to more than $622 billion in little more than ten years.5 Here we can see that diabetes ranks among the fast-growing chronic diseases in the U.S.: 2. The prediabetes pipeline For an indication of the future type 2 diabetic population, one need only look at the current population of people with prediabetes, a condition defined by elevated blood sugar levels.1 Although patients with elevated blood sugar levels can avert type 2 diabetes with changes to their lifestyle, of the 86 million p Continue reading >>
Lifetime Cost For Type 2 Diabetes Mellitus In Singapore
Abstract Background The mean annual direct medical cost of type 2 diabetes mellitus (T2DM) in Singapore has been found to be SGD 2034 using the prevalence-based approach, but the lifetime direct medical cost of T2DM in Singapore remains largely unknown. The aim of the present study was to determine the lifetime direct medical cost attributable to T2DM and provide estimates of potential savings if T2DM can be prevented or delayed. Methods The incidence-based approach was used for the cost-of-illness analysis. Yearly medical expenses were obtained from a regional health system database in Singapore to estimate the lifetime medical cost of T2DM patients. Then, the lifetime medical cost of non-T2DM subjects was predicted using a regression model. From the database, gender- and age-specific annual survival rates of T2DM and non-T2DM subjects were obtained and survival-adjusted yearly expenses over the estimated remaining life span were added to obtain lifetime medical costs. The difference between T2DM and non-T2DM subjects was attributed to excess direct medical costs of T2DM. The excess lifetime medical expenses for T2DM patients were SGD 132 506, 108 589, 83 326 and 70 110 when the age of T2DM diagnosis was 40, 50, 60, and 65 years, respectively. Conclusions Even though T2DM patients have a lower life expectancy, T2DM is associated with substantially higher lifetime medical costs. Delaying the onset of T2DM, especially in the young, may lead to lower lifetime medical expenses. If prevention costs can be kept sufficiently low, effective T2DM prevention efforts would likely lead to a reduction in long-term medical costs. Continue reading >>
The Cost Of Diabetes In The U.s.: Economic And Well-being Impact
IN HONOR OF WORLD DIABETES DAY AND NATIONAL DIABETES AWARENESS MONTH According to the Gallup-Sharecare Well-Being Index™, the national prevalence of diabetes increased from 10.6% in 2008 to 11.5% for the first nine months of 2017. This increase has had a direct impact on health care costs and health outcomes. If the diabetes rate had remained at its 2008 level, approximately 2.3 million fewer U.S. adults would have the disease today, and healthcare costs due to diabetes would be an estimated $19.2 billion less than current levels. Costs to employers are significant with more than $20 billion annually in lost productivity, stemming from 57 million additional unplanned missed workdays by workers with diabetes. Further, the residents of the U.S. communities with the highest prevalence of diabetes have higher rates of obesity, high blood pressure, high cholesterol, heart attack and depression and are less likely to engage in healthy behaviors than residents in the lowest prevalence communities. This Gallup and Sharecare research also examines diabetes and its relationship to key well-being and productivity outcomes. It also addresses how health systems are leveraging best practices to expand diabetes management both within the hospital setting and out to the communities they serve. To learn more, click here The Cost of Diabetes in the U.S.: Economic and Well-Being Impact. Continue reading >>
Managing The Cost Of Diabetes
Diabetes is one of the most common and costly chronic diseases, affecting more than 30 million Americans, with a total annual cost of $245 billion.1 Prevalence continues to increase as obesity rises, with the highest rates of diabetes found in minorities and older Americans. Consequences of diabetes include hypertension, coronary heart disease, stroke, chronic kidney disease, and blindness.2 Despite significant medical advancement in treatment, diabetes remains the seventh leading cause of death in the United States.3 As a result, health care providers must consider the impact of financial and educational barriers in outcomes associated with diabetic management. Diabetes is associated with a significant financial burden both to the patient and to the health care system. In 2012, the estimated cost of direct med- ical care in diabetes was $176 billion.1 The cost of prescription medications accounted for 18% of that cost, while diabetic supplies accounted for 12%.1 Individuals with diabetes had more than double the cost of annual medical expenditures compared with those without, with an average annual cost of $13,700.1 Although government and private insurance provide patient assistance in managing these costs, financial barriers may still pose a significant obstacle to patients in optimizing diabetic management. Patients who are unable to afford their medications and diabetic supplies will have less than optimal control of their blood sugar and glycated hemoglobin, putting them at increased risk for diabetic complications. Current guidelines provide detailed stepwise recommendations for initiation and adjustment of oral and injectable glycemic agents. A wide variety of agents are available for management of diabetes. However, agent utilization and medication compliance m Continue reading >>
More Than 100 Million Americans Have Diabetes, Prediabetes
The National Diabetes Statistics Report, released every two years, finds that as of 2015, 30.3 million Americans, or 9.4 percent of the U.S. population, have diabetes — a disease in which the body's ability to produce or respond to the hormone insulin is impaired. Another 84.1 million have prediabetes, a condition which, if not treated, can lead to type 2 diabetes within five years. The largest portion of the population with diabetes was over 45: Among people ages 18 to 44, 4 percent had diabetes. Among people ages 45 to 64 years, 17 percent had diabetes. Among people 65 and older, 25 percent had diabetes. The study also found that nearly 1 in 4 adults living with diabetes, or 7.2 million Americans, didn’t know they had it. Only 11.6 percent of adults with prediabetes were aware of the condition. Diabetes was the seventh leading cause of death in the United States in 2015, and the direct and indirect estimated cost of diabetes in the United States was $245 billion. Average medical expenditures were $13,700 per year, and about $7,900 of this amount was attributed to diabetes. After adjusting for age group and gender, average medical expenditures among people with diagnosed diabetes were about 2.3 times higher than the general population. Raising awareness about prediabetes To reduce the impact of prediabetes and type 2 diabetes, the CDC established the National Diabetes Prevention Program (National DPP), which includes a behavior change program to improve eating habits and increase physical activity. Even modest weight loss has been shown to significantly reduce the risk of type 2 diabetes. The CDC is also partnering with the American Diabetes Association, the American Medical Association and the Ad Council to launch the first national public service advertising camp Continue reading >>
The Cost Of Diabetes In The U.s.: Economic And Well-being Impact
Proud of com m unity2+ days of poor health preventing usual activities Little interest or pleasure in doing things Learn or do something interesting every day Use strengths every day Life evaluatio n (% thriving) Den tal visi ts He alt hc ar e i ns ec ur ity Ha ve h ea lth in su ra nc e Di ab et es Ob es ity Hig h b loo d p res sur e High cho lest erol Heart atta ck Depression Physical pain Healthy eating Regular exercise Sm oking Healthcare Access Health B eha vior s Pr od uc tiv ity & Vit alit y Disease Burden 80% 20% 40% 60% Comparison of 10 Lowest & 10 Highest Diabetes Prevalence Communities, 2015/2016 2 Diabetes and Relationship to Key Well-Being and Productivity Metrics While most clinicians agree that managing diabetes improves health and reduces medical costs, the benefit to employers also extends to a more productive workforce. An opportunity exists for employers to partner with the medical community, specifically Certified Diabetes Educators at local and regional hospitals, to offer diabetes education and training to their employees with diabetes. This collaboration has tangible and proven value for both the individual and the company’s bottom line. – Sheila Holcomb, RD, LD, CDE, Vice President, Sharecare Diabetes Solution This report, part of the Gallup-Sharecare State of American Well-Being series, examines the relationship of diabetes with important well-being metrics and presents an analysis of the cost of diabetes on key aspects of the U.S. economy. Overall, the prevalence of diabetes in the U.S. adult population is growing, up a full percentage point in the last eight years, from 10.6% in 2008 to 11.6% in 2016, and at 11.5% for the first nine months of 2017. The rising prevalence, not surprisingly, has increased healthcare costs. If the dia Continue reading >>
5 Effective Ways Employers Can Address Diabetes Costs
Every 23 seconds someone in the U.S is diagnosed with diabetes. According to the Centers for Disease Control and Prevention (CDC), more than 29 million Americans are diabetic, and 86 million more have prediabetes. Together, these two groups comprise about 45 percent of the U.S. workforce. Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership. Benefits: Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital member, you’ll receive: Critical BenefitsPRO.com information including cutting-edge post-reform success strategies, comprehensive service provider listings, educational webcasts and videos, resources from industry leaders, and informative eNewsletters. Exclusive discounts on ALM, BenefitsPRO Magazine and BenefitsPRO.com events. Access to other award-winning ALM publications including ThinkAdvisor.com and Law.com. Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership. Benefits: Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital member, you’ll receive: Critical BenefitsPRO.com information including cutting-edge post-reform success strategies, comprehensive service provider listings, educational webcasts and videos, resources from industry leaders, and informative eNewsletters. Exclusive discounts on ALM, BenefitsPRO Magazine and BenefitsPRO.com events. Access to other award-winning ALM publications including ThinkAdvisor.com and Law.com. Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership. Benefits: Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital Continue reading >>
One Third Of Americans Are Headed For Diabetes, And They Don't Even Know It
One third of Americans may be on their way to developing full-blown type 2 diabetes, and most of them don't even know it. A recent report from The Centers for Disease Control and Prevention (CDC) shows that more than 84 million Americans, or roughly one-third of the population, have prediabetes, a condition marked by higher-than-normal blood sugar. Of that group, 90 percent aren't aware they have the condition. The primary risk factors for type 2 diabetes are genetics and lifestyle — excess weight, obesity and lack of exercise contribute to this alarming medical trend. "People with prediabetes who don't change their lifestyle are at a much higher risk of developing heart disease and stroke and can develop type 2 diabetes within five years if left untreated," said William T. Cefalu, MD, chief scientific, medical & mission officer of the American Diabetes Association. The health risks go beyond heart disease and stroke. As diabetes worsens over time, blindness, kidney disease and lower-limb amputation are also major health risks. Diabetes was the seventh-leading cause of death in the United States in 2015, according to the CDC. This population of diabetes "ticking time bombs" is particularly alarming, because in many cases type 2 diabetes can be avoided, simply by leading a healthy lifestyle. Type 2 diabetes is often progressive, and within 10 years of diagnosis, 50 percent of individuals need to use insulin to control their blood glucose levels, according to the ADA. More than 30 million Americans — 9.4 percent of the U.S. population — are already battling diabetes, according to the CDC's National Diabetes Statistics Report, which used data through 2015. The CDC found that of those cases, 7.2 million were undiagnosed. "The country needs to take this seriously, ratc Continue reading >>
The Global Economic Burden Of Diabetes In Adults Aged 20–79 Years: A Cost-of-illness Study
Summary Differences in methods and data used in past studies have limited comparisons of the cost of illness of diabetes across countries. We estimate the full global economic burden of diabetes in adults aged 20–79 years in 2015, using a unified framework across all countries. Our objective was to highlight patterns of diabetes-associated costs as well as to identify the need for further research in low-income regions. Epidemiological and economic data for 184 countries were used to estimate the global economic burden of diabetes, regardless of diabetes type. Direct costs were derived using a top-down approach based on WHO general health expenditure figures and prevalence data from the 2015 International Diabetes Federation Diabetes Atlas. Indirect costs were assessed using a human-capital approach, including diabetes-associated morbidity and premature mortality. We estimate the global cost of diabetes for 2015 was US$1·31 trillion (95% CI 1·28–1·36) or 1·8% (95% CI 1·8–1·9) of global gross domestic product (GDP). Notably, indirect costs accounted for 34·7% (95% CI 34·7–35·0) of the total burden, although substantial variations existed both in the share and the composition of indirect costs across countries. North America was the most affected region relative to GDP and also the largest contributor to global absolute costs. However, on average, the economic burden as percentage of GDP was larger in middle-income countries than in high-income countries. Our results suggest a substantial global economic burden of diabetes. Although limited data were available for low-income and middle-income countries, our findings suggest that large diabetes-associated costs are not only a problem in high-income settings but also affect poorer world regions. This articl Continue reading >>
The True Cost Of Diabetes And Preventing It
From our publisher, Steve Freed, comes this thought-provoking discussion of how better diabetes control can impact cost, quality of life and mortality… Epidemiological study cohorts have shown a gradual increase in the worldwide incidence of type 2 diabetes mellitus. Based on the National Diabetes Statistics Report, 2014, 29 million people in the U.S. have diabetes aged 20 years or older (12.3% of the adult population), and 1 in 4 do not know it. This number has increased from 26 million in 2010. In 2012 alone, 1.7 million people aged 20 years or older were newly diagnosed with diabetes. Eighty-six million people aged 20 years and older have pre-diabetes, and if no precautions or actions are taken, 15-30% of people with pre-diabetes will develop type 2 diabetes within 5 years. Diabetes and its related complications account for $245 billion in total medical costs to include lost work and wages. This number is up from the reported $174 billion in 2010. In addition, over $500 billion of an estimated $3 trillion spent on healthcare last year was spent on conditions related to three chronic diseases: diabetes, heart disease and obesity. In the United States, the number of Emergency Department visits with diabetes as any-listed diagnosis increased from 9,464,000 in 2006 to 11,492,000 in 2009. Based on studies the average lifetime cost of caring for a type 2 diabetic patient is approximately $85,200 and can range from $55,000 to $130,000. Studies have shown that better control of diabetes can reduce cost, increase quality of life, and decrease mortality rate. One study showed that just by reducing A1c by 1% to 1.5%, type 2 diabetic patients can cut costs to $1,717 per target patient over 1 year. Prevention efforts nationwide are very crucial right now to combat serious healt Continue reading >>
Healthcare Costs And Resource Utilization Based On Diabetes And Cardiovascular Risk Factor Profile
Editor's Note: Commentary based on Feldman DI, Valero-Elizondo J, Salami JA, et al. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS). Atherosclerosis 2017;258:79-83. Introduction According to the Centers for Disease Control and Prevention (CDC), the national healthcare expenditure in 2014 was $3 trillion, which was 17.5% of the gross domestic product (GDP) of the United States.1 Moreover, healthcare expenditure has increased considerably over the last decade.2 Of this exorbitant spending on healthcare, a significant portion is spent on diabetes and cardiovascular disease management. More than 23% of the healthcare expenditure is incurred by patients with diabetes and 17% of the national expenditure is attributable to cardiovascular disease management.3,4 Diabetes and cardiovascular disease are not two separate categories from a financial perspective. More than 7.6 million patients with diabetes in the United States have a history of heart disease or stroke, and the healthcare expenditure is exceptionally high in these patients.5 One study demonstrated that 26% of hospital inpatient costs and 14% of outpatient visit costs are attributable to cardiovascular disease in diabetes patients.3 What about patients with diabetes and a high cardiovascular disease risk? It seems intuitive that patients with diabetes and a poor cardiovascular risk factor (CRF) profile would use more healthcare resources and have high healthcare costs. Surprisingly, there has been a paucity of research investigating the financial aspect and resource utilization in this group of patients. Study Highlights In th Continue reading >>
- Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?
- Maternal obesity as a risk factor for early childhood type 1 diabetes: a nationwide, prospective, population-based case–control study
- Diabetes Care Management Teams Did Not Reduce Utilization When Compared With Traditional Care: A Randomized Cluster Trial
Gallup And Sharecare Release New Research On The Cost Of Diabetes To U.s. Communities And Employers
WASHINGTON and ATLANTA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- World-leading analytics and advice firm, Gallup, and Sharecare, the digital health company helping people manage all their health in one place, have released new research from the Gallup-Sharecare Well-Being Index on the cost and well-being implications of diabetes to U.S. communities and the economy. The new research coincides with World Diabetes Day and serves as a valuable resource for providers, employers and community leaders, as they address this rising epidemic within their populations. The prevalence of diabetes increased from 10.6% in 2008 to 11.5% for the first nine months of 2017, an increase which has had a direct impact on health care costs and health outcomes. If the diabetes rate had remained at its 2008 level, about 2.3 million fewer U.S. adults would have the disease today, and healthcare costs due to diabetes would be an estimated $19.2 billion less than current levels. Costs to employers are significant with more than $20 billion annually in lost productivity, stemming from 57 million additional unplanned missed workdays by workers with diabetes. The new research also analyzes the impact of diabetes on communities. Those communities with the highest prevalence of diabetes have residents with higher disease burden including higher obesity rates, heart disease, diagnosed depression, and physical pain. The higher prevalence communities also have fewer residents who exhibit healthy behaviors – a lower percentage of residents exercise regularly, fewer eat healthy, and more residents smoke. By contrast, communities with low diabetes rates are more likely to have residents who are productive and vital based on key purpose and community well-being metrics, including using strengths daily, learning or Continue reading >>
Type 2 Diabetes Statistics: Facts And Trends
Diabetes mellitus, or diabetes, is a disease that causes high blood sugar. It occurs when there is a problem with insulin. Insulin is a hormone that takes sugar from foods and moves it to the body's cells. If the body does not make enough insulin or does not use insulin well, the sugar from food stays in the blood and causes high blood sugar. There are several different types of diabetes, but the most common is type 2. According to the Centers for Disease Control and Prevention's (CDC) National Diabetes Report, 2014, 90 to 95 percent of people with diabetes in the United States have type 2. Just 5 percent of people have type 1. Contents of this article: Key facts about diabetes in the U.S. Diabetes is at an all-time high in the U.S. The CDC's Division of Diabetes Translation states that 1 percent of the population, which is about a half of a million people, had diagnosed diabetes in 1958. Today, nearly 10 percent of the population have diabetes, according to the American Diabetes Association (ADA). That's 29.1 million Americans, and more than a quarter of these people do not know they have it. The ADA report that the number of people who have diabetes increased by 382 percent from 1988 to 2014. The risk of developing diabetes increases with age. The CDC report that 4.1 percent of people age 20-44 have diabetes, but the number jumps to 25.9 percent for people over 65 years old. As obesity has become more prevalent over the past few decades, so too has the rate of type 2 diabetes. An article in the Journal of Diabetes Science and Technology states that 25.6 percent of Americans are obese, much higher than the 15.3 percent of obese people in 1995. In that same period, the incidence of diabetes increased by 90 percent. Although the link between obesity and diabetes is well Continue reading >>
